Essenlix Corporation
PrivateLast Round
Series A
Aug 9, 2018
Total Funding Raised
$20M
Company Overview
Essenlix Corporation is a health diagnostics company that develops iMOST, a mobile, instant self-test platform for various diseases and health-related biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Health IoT, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Essenlix Corporation Comps
Public and private peers based on sector, stage, and business model.
Essenlix Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 9, 2018 |
Essenlix Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NPX Capital Private Equity | Series A |
| Quadrant Management | Series A |
Essenlix Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Essenlix Corporation's valuation, stock price, and market status.
